Algert Global LLC Mersana Therapeutics, Inc. Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 63,483 shares of MRSN stock, worth $129,505. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,483

Previous 44,655 42.16%

Holding current value

$129,505

Previous $90,000 33.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.23 - $2.25 $23,158 - $42,363	18,828 Added 42.16%	63,483 $120,000
Q2 2024 Aug 14, 2024	BUY	$2.0 - $4.45 $89,310 - $198,714	44,655 New	44,655 $90,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $580,580 - $1.8 Million	188,500 Added 601.35%	219,846 $723,000
Q1 2023 May 12, 2023	SELL	$4.0 - $7.02 $109,248 - $191,730	-27,312 Reduced 46.56%	31,346 $129,000
Q3 2022 Nov 15, 2022	BUY	$4.63 - $8.0 $271,586 - $469,264	58,658 New	58,658 $397,000
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $93,881 - $166,426	-25,102 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $39,510 - $71,090	7,210 Added 40.3%	25,102 $156,000
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $153,155 - $258,897	17,892 New	17,892 $169,000
Q1 2021 May 14, 2021	SELL	$15.31 - $26.52 $142,566 - $246,954	-9,312 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$16.84 - $27.59 $156,814 - $256,918	9,312 New	9,312 $248,000
Q3 2020 Nov 16, 2020	SELL	$16.2 - $25.7 $551,788 - $875,367	-34,061 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$5.24 - $23.4 $40,976 - $182,988	-7,820 Reduced 18.67%	34,061 $797,000
Q1 2020 May 13, 2020	SELL	$4.41 - $9.28 $44,761 - $94,192	-10,150 Reduced 19.51%	41,881 $244,000
Q4 2019 Feb 18, 2020	BUY	$1.45 - $6.73 $19,285 - $89,509	13,300 Added 34.34%	52,031 $298,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $68,344 - $113,907	17,798 Added 85.02%	38,731 $157,000
Q1 2019 May 01, 2019	BUY	$3.51 - $7.3 $73,474 - $152,810	20,933 New	20,933 $110,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Mersana Therapeutics, Inc. Transaction History